Drug Pipeline

68Ga-DOTATATE Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
4
Recruiting
4
Top Sponsors
Active Studies by Phase
Phase 2
2
Phase 1/2
1
Phase 1
1
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07284589 Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake Healthy (Controls) Recruiting
NCT02019706 Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in… ACTH Recruiting
Phase 1/2
NCT06427798 Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable… Somatostatin Receptor Positive Recruiting
Phase 1
NCT06479811 [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive… Somatostatin Receptor Positive Recruiting
Early Phase 1
NCT04040088 An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic… Ganglioneuroblastoma Active, Not Recruiting
Sponsors Running 68Ga-DOTATATE Trials
National Cancer Institute (NCI) (2) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) Mayo Clinic (1) Akiva Mintz (1)
Disease Areas
Glioma (2) Small Cell Lung Cancer (1) Lung Cancer (1) Kidney Cancer (1)
Get alerts when 68Ga-DOTATATE trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free